Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 6 of 6 for “"biologic DMARDS"”.

  1. Factors associated with the initiation of biologic disease modifying antirheumatic drugs in Texas Medicaid patients with rheumatoid arthritis

    … and yet lacks guidance on how early to initiate biologic disease-modifying antirheumatic drugs (DMARDs), a class of medications that is the major cost driver in RA management. The main purpose of this study was to examine patient socio-demographics, medication use patterns, and clinical …

    texas Repository record for Factors associated with the initiation of biologic disease modifying antirheumatic drugs in Texas Medicaid patients with rheumatoid arthritis (opens in a new tab)

  2. An OLS-Based Method for Causal Inference in Observational Studies

    … evaluating the effect of early combination of biologic & non-biologic disease-modifying antirheumatic drugs (DMARDs) compared to step-up treatment plan in children with newly onset of juvenile idiopathic arthritis disease (JIA). The proposed method gives strong evidence of significant effect of …

    iupui Repository record for An OLS-Based Method for Causal Inference in Observational Studies (opens in a new tab)

  3. The impact of 340B disruption on patients with autoimmune rheumatic diseases

    … rely on disease-modifying antirheumatic drugs (DMARDs) to manage disease progression. AIRD patients are often prescribed biologic DMARDs (bDMARDs), which increases the financial burden of treatment. Since 1992, qualifying covered entities, such as University Health and Lakewood Medical Center, …

    umkc Repository record for The impact of 340B disruption on patients with autoimmune rheumatic diseases (opens in a new tab)

  4. Assessing The Comparative Effect Of Tocilizumab On Risk Of Cardiovascular Disease Among Rheumatoid Arthritis Patients Using Claims Data: A Direct Comparison Among Biologic Disease-Modifying Antirheumatic Drugs

    … USING CLAIMS DATA: A DIRECT COMPARISON AMONG BIOLOGIC DISEASEMODIFYING ANTIRHEUMATIC DRUGS FENGLONG XIE PhD-EPID ABSTRACT Tocilizumab is a humanized monoclonal anti-body against the interleukin-6 receptor and is effective in the treatment of rheumatoid arthritis (RA) [1]. Multiple studies have …

    uab Repository record for Assessing The Comparative Effect Of Tocilizumab On Risk Of Cardiovascular Disease Among Rheumatoid Arthritis Patients Using Claims Data: A Direct Comparison Among Biologic Disease-Modifying Antirheumatic Drugs (opens in a new tab)